The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant buzz within the United Kingdom , prompting a notable shift in medication trends. Availability these treatments remains a complex landscape, with public healthcare system approval currently limited and independent providers offering prescriptions at a higher